This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Columbia University, University of Ghent. Active years: 2016-2017.
Company Filing History:
2 out of 618 
1 out of 2,551 
1 out of 505 
Years Active: 2016-2017
Title: Elisa Oricchio: Innovator in Cancer Research
Introduction
Elisa Oricchio is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer research. With a focus on microRNAs and their role in cancer treatment, she has been awarded 2 patents that highlight her innovative approaches to diagnosing and managing cancer.
Latest Patents
Her latest patents include groundbreaking methods and compositions for the detection and treatment of cancer involving microRNAs (miRNAs) and miRNA inhibitors. One patent specifically addresses T-cell acute lymphoblastic leukemia (T-ALL), detailing methods for modulating miRNAs to improve treatment outcomes. Another patent focuses on identifying a novel subtype of follicular lymphoma characterized by dysregulation of the cyclin/CDK/RB proliferative pathway, presenting new therapies for patients with this subtype.
Career Highlights
Elisa has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Columbia University. Her work has been pivotal in advancing the understanding of cancer biology and developing targeted therapies.
Collaborations
Throughout her career, Elisa has collaborated with notable colleagues, including Hans-Guido Wendel and Kim De Keersmaecker, further enhancing her research impact.
Conclusion
Elisa Oricchio's innovative work in cancer research exemplifies the vital role of inventors in advancing medical science. Her contributions continue to influence the field and offer hope for improved cancer treatments.